Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02096055
Title 4-Arm Phase II Study of SGI-110 in Elderly Acute Myeloid Leukemia (AML)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

Therapies

Cladribine

Guadecitabine

Idarubicin

Age Groups: senior
Covered Countries USA


No variant requirements are available.